Considered the world’s largest event on HIV/AIDS, the 24th International AIDS Conference (AIDS 2022) will be held in Montreal, Canada, from July 29 to August 2, with the main objectives of mobilizing the world to unite around science, set future research agendas, turn the latest evidence into action, and forge a new consensus on overcoming the HIV epidemic as a threat to public health and individual well-being.

Once again, ImPrEP will be present at the event with a diversified program, mainly around HIV pre-exposure prophylaxis (PrEP), including the organization of the satellite symposium “Evidence on the implementation of  PrEP in Latin America: results from the project ImPrEP”, in addition to the presentation of various posters.

Special mention goes to the participation of Beatriz Grinsztejn, head of the STD/AIDS Clinical Research Laboratory, at the Evandro Chagas National Institute of Infectious Diseases (INI/Fiocruz) and ImPrEP principal co-investigator, in one of the most important sessions of the event. The Prime Session will bring together renowned experts to address the topic “HIV Prevention and Treatment”, on July 31, at 4:30 PM (GMT-4). Beatriz was recently elected president of the International AIDS Society for the 2024-2026 term.

Another highlight will be the special participation of Valdiléa Veloso, director of INI/Fiocruz and ImPrEP principal investigator, at the Latin & Inter Regional Forum On Emerging Topics in HIV 2022, an independent affiliated event at AIDS 2022, on July 28, at 2:50 pm (GMT-4). Valdiléa will address the Current Situation of PrEP in Emerging Countries. The event will bring together experts from Spain, Argentina, the United States, Mexico and Saudi Arabia.

Check out the full list ofImPrEP activities atAIDS 2022:

Satellite Symposium

“Evidence for PrEP implementation in Latin America: ImPrEP Project results” (SA102)

August 2nd (available to conference delegates from  8:00 AM (GMT-4)

Topics and ImPrEP participants:

-“Opening remarks”, with Gerson Pereira (Ministry of Health, Brazil)

– “PrEP outcomes among men who have sex with men (MSM) and transgender women (TGW) in Brazil – results and lessons learned from the ImPrEP study”, with Valdiléa Veloso (National Institute of Infectious Diseases Evandro Chagas – INI/Fiocruz, Brazil)

– “The ImPrEP outcome in Mexico: implementing PrEP in public health and community services”, with Hamid Vega-Ramírez (National Institute of Psychiatry Ramon de La Fuente Muñiz, Mexico)

–  “Focusing on PrEP discontinuation among those most vulnerable to HIV in Peru: challenges ahead for Latin America”,with Carlos Cáceres (Cayetano Heredia Peruvian University – UPCH)

– “The situation of  PrEP in the LAC Region: implementation, challenges and opportunities”, with Hortencia Peralta (Pan American Health Organization)

– “The way forward – ImPrEP and CAB LA”, with Beatriz Grinsztejn (INI/Fiocruz, Brazil)

Posters

-“Awareness of  U=U among sexual and gender minorities in Brazil, Mexico, and Peru: differences according to self-reported HIV status”, with Kelika Konda (UPCH) et al, for the ImPrEP Study Group (PESAE12)

-“HIV self-testing to increase combination prevention demand among MSM and TGW: a randomized clinical trial and sub-study of the ImPrEP project”, with  Kelika Konda (UPCH) et al, for the ImPrEP Study Group  (EPC363)

-“Profiles of PrEP modality preferences among Brazilian, Mexican, and Peruvian sexual and gender minorities”, with Kelika Konda (UPCH) et al, for the ImPrEP Study Group (EPC183)

– “Qualitative study on PrEP implementation among MSM and TGW in Brazil: the user’s perspectives”, with M. Benedetti (INI/Fiocruz) et al, for the ImPrEP Study Group (EPC203)

-“Comparing the characteristics of Brazilian MSM according to recruitment strategy: on-line approach as an useful tool during COVID-19 pandemic”, with Thiago Torres (INI/Fiocruz) et al, for the ImPrEP DCE Study Group (EPC157)

-“Changes in awareness and willingness to use PrEP among MSM in Latin America between 2018 and 2021: results from the ImPrEP project”, with Thiago Torres (INI/Fiocruz) et al, for the ImPrEP Study Group (EPC182)

-“An evaluation of the HIV risk screening and enrollment process in Mexico’s PrEP demonstration project— the ImPrEP study”, with Heleen Vermandere (National Institute of Public Health, Mexico – INSP) et al (EPC175)

-“The PrEP care continuum among MSM and TGW: ImPrEP Mexico”, with Santiago Aguilera-Mijares (INSP) et al (EPC172)

-“PrEP and telemedicine in times of COVID-19: experiences of  health professionals in Mexico”, with Alma Cruz Bañares (INSP) et al (EPC177)

-“Sexual behavior and HIV prevalence among Venezuelans immigrants in Peru: a study among MSM and TGW screened for PrEP”, with Oliver A. Elorreaga (UPCH) et al, for the ImPrEP Study Group (PESAC08)

-“Health care providers’perspectives on PrEP adherence among MSM and TGW in Peru: a qualitative study of the ImPrEP demonstration study”, with J. P. Jirón Sosa (UPCH) et al (EPC256)

– “Which are the most valued PrEP attributes? A discrete choice experiment among MSM and TGW in Peru”, with Oliver A. Elorreaga (UPCH) et al, for the ImPrEP Study Group (EPC275)